ReviewJournal of hematology & oncology2022

Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance.

Kai Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.